Page last updated: 2024-08-23
radium and psma-617
radium has been researched along with psma-617 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ahmadzadehfar, H; Baum, RP; Bögemann, M; Fimmers, R; Garcia-Perez, FO; Gerke, C; Ilhan, H; Kabasakal, L; Kairemo, K; Kessel, K; Kratochwil, C; Kulkarni, HR; Maffey-Steffan, J; Maharaj, M; Paez, D; Rahbar, K; Rathke, H; Sathekge, M; Seifert, R; Virgolini, I; Zhang, J | 1 |
| Ahmadzadehfar, H; Baum, RP; Bögemann, M; Garcia-Perez, FO; Ilhan, H; Kabasakal, L; Kairemo, K; Kessel, K; Kratochwil, C; Maharaj, M; Matern, R; Paez, D; Rahbar, K; Rathke, H; Sathekge, M; Seifert, R; Svirydenka, H; Virgolini, I; Yordanova, A | 1 |
Other Studies
2 other study(ies) available for radium and psma-617
| Article | Year |
|---|---|
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [
Topics: Aged; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Male; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Radium; Retrospective Studies; Treatment Outcome | 2021 |
The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [
Topics: Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Treatment Outcome | 2021 |